Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jennifer Kiser

Concepts (362)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antiviral Agents
34
2026
767
6.090
 Why?
Hepatitis C
15
2026
256
4.320
 Why?
Hepatitis C, Chronic
15
2026
153
3.980
 Why?
Anti-HIV Agents
35
2025
908
3.930
 Why?
HIV Infections
56
2025
3186
3.820
 Why?
Adenine
30
2025
338
3.810
 Why?
Sofosbuvir
14
2026
61
3.720
 Why?
Ribavirin
15
2020
81
3.600
 Why?
Drug Interactions
21
2019
404
3.100
 Why?
Tenofovir
31
2025
300
2.990
 Why?
Tandem Mass Spectrometry
17
2025
571
2.130
 Why?
Hepacivirus
13
2026
242
1.960
 Why?
Proline
6
2026
82
1.810
 Why?
Dried Blood Spot Testing
13
2024
126
1.730
 Why?
Oligopeptides
8
2015
266
1.660
 Why?
Organophosphates
16
2025
179
1.650
 Why?
Emtricitabine
19
2025
209
1.600
 Why?
Organophosphonates
12
2014
95
1.470
 Why?
Benzimidazoles
8
2026
189
1.400
 Why?
Ritonavir
8
2021
75
1.360
 Why?
Protease Inhibitors
4
2020
102
1.320
 Why?
Chromatography, Liquid
14
2025
450
1.220
 Why?
Coinfection
5
2024
143
1.200
 Why?
Phosphorous Acids
3
2019
15
1.120
 Why?
Fluorenes
4
2020
45
1.030
 Why?
Pyrophosphatases
3
2016
26
1.010
 Why?
Hepatitis B
4
2024
66
0.990
 Why?
Nucleotides
3
2016
129
0.990
 Why?
Drug Monitoring
8
2024
399
0.920
 Why?
Anti-Retroviral Agents
5
2019
251
0.870
 Why?
Drug Therapy, Combination
12
2018
1043
0.810
 Why?
Sulfonamides
6
2026
583
0.810
 Why?
Pyridines
5
2015
608
0.740
 Why?
Polyphosphates
7
2022
43
0.720
 Why?
Humans
104
2026
145140
0.710
 Why?
Cell Phone
1
2022
82
0.700
 Why?
Reverse Transcriptase Inhibitors
5
2014
87
0.700
 Why?
Erythrocytes
8
2016
747
0.700
 Why?
HIV Protease Inhibitors
5
2011
69
0.700
 Why?
Carbamates
3
2026
50
0.680
 Why?
Membrane Transport Proteins
4
2016
153
0.670
 Why?
Simeprevir
2
2018
5
0.670
 Why?
Viral Load
11
2024
525
0.660
 Why?
Isoniazid
3
2026
70
0.660
 Why?
HIV-1
7
2021
906
0.650
 Why?
Mobile Applications
1
2022
199
0.610
 Why?
Therapies, Investigational
1
2019
18
0.610
 Why?
Antitubercular Agents
3
2026
208
0.590
 Why?
Heterocyclic Compounds, 3-Ring
2
2023
44
0.580
 Why?
Medication Adherence
12
2022
540
0.570
 Why?
Respiratory Syncytial Virus Infections
1
2020
139
0.570
 Why?
Leukocytes, Mononuclear
9
2025
573
0.560
 Why?
Adult
47
2026
40665
0.550
 Why?
Ethanol
1
2023
631
0.550
 Why?
Male
57
2026
72664
0.540
 Why?
Pyridazines
2
2021
57
0.540
 Why?
Antiretroviral Therapy, Highly Active
4
2015
279
0.530
 Why?
Solid Phase Extraction
2
2014
25
0.520
 Why?
Middle Aged
40
2026
36126
0.520
 Why?
Lung Transplantation
1
2020
329
0.500
 Why?
Pyrimidinones
2
2008
125
0.500
 Why?
HIV Integrase Inhibitors
1
2018
79
0.500
 Why?
Inosine
1
2016
14
0.490
 Why?
Liver
2
2016
1893
0.490
 Why?
Tuberculosis
3
2026
283
0.490
 Why?
Guanosine
1
2016
40
0.490
 Why?
Pharmacogenomic Variants
1
2016
34
0.480
 Why?
Heterocyclic Compounds, 4 or More Rings
2
2026
23
0.460
 Why?
Female
53
2026
78636
0.460
 Why?
Purines
1
2016
186
0.460
 Why?
Chromatography, High Pressure Liquid
2
2015
591
0.450
 Why?
Drug Discovery
1
2016
153
0.440
 Why?
Serum
1
2015
58
0.430
 Why?
Adenosine
1
2016
255
0.430
 Why?
Intracellular Space
1
2014
64
0.420
 Why?
Kidney
4
2016
1494
0.420
 Why?
Priapism
1
2013
10
0.400
 Why?
Receptors, Adrenergic, alpha
1
2013
19
0.400
 Why?
HIV
4
2019
251
0.400
 Why?
Adrenergic alpha-Antagonists
1
2013
34
0.400
 Why?
Cytochrome P-450 CYP3A Inhibitors
1
2013
18
0.390
 Why?
Deoxycytidine
6
2017
220
0.390
 Why?
Treatment Outcome
15
2026
11741
0.390
 Why?
Telemedicine
1
2022
956
0.390
 Why?
Pre-Exposure Prophylaxis
5
2020
268
0.380
 Why?
Quinoxalines
2
2026
65
0.370
 Why?
Hepatitis B, Chronic
3
2022
22
0.370
 Why?
Hepatitis B virus
4
2024
33
0.370
 Why?
Genotype
7
2026
1844
0.360
 Why?
Gastric Bypass
1
2014
126
0.360
 Why?
Pyrrolidines
2
2026
125
0.360
 Why?
Area Under Curve
5
2026
329
0.350
 Why?
Phenotype
2
2016
3138
0.340
 Why?
Alanine
5
2025
168
0.330
 Why?
HIV Seronegativity
1
2010
29
0.330
 Why?
Antacids
1
2010
16
0.330
 Why?
Pyrrolidinones
1
2010
29
0.320
 Why?
Prospective Studies
17
2022
8035
0.320
 Why?
Pyrimidines
3
2021
530
0.310
 Why?
Patient Compliance
3
2017
587
0.310
 Why?
Pharmacy Service, Hospital
1
2011
89
0.300
 Why?
Blood Chemical Analysis
4
2019
109
0.300
 Why?
Plasma
4
2016
223
0.300
 Why?
Reproducibility of Results
8
2016
3410
0.290
 Why?
Pregnancy Complications, Infectious
3
2025
438
0.290
 Why?
Uridine Monophosphate
2
2019
16
0.290
 Why?
Sustained Virologic Response
4
2026
46
0.290
 Why?
Drug Prescriptions
1
2011
287
0.280
 Why?
Adolescent
21
2026
22479
0.270
 Why?
Fluorobenzenes
1
2008
17
0.270
 Why?
Drug Stability
5
2016
169
0.260
 Why?
Young Adult
17
2025
14176
0.260
 Why?
Guidelines as Topic
1
2009
266
0.260
 Why?
Liver Transplantation
1
2014
826
0.250
 Why?
Atazanavir Sulfate
5
2015
42
0.250
 Why?
Sensitivity and Specificity
5
2014
1995
0.250
 Why?
Half-Life
3
2015
153
0.240
 Why?
Anti-Ulcer Agents
1
2006
12
0.240
 Why?
Esomeprazole
1
2006
7
0.240
 Why?
Glycerophospholipids
2
2023
39
0.240
 Why?
Pharmacology, Clinical
1
2006
9
0.240
 Why?
Cyclopropanes
3
2026
84
0.230
 Why?
Hepatocytes
3
2016
224
0.230
 Why?
Education
1
2006
104
0.230
 Why?
Proton Pump Inhibitors
1
2006
109
0.220
 Why?
Aminoisobutyric Acids
2
2026
9
0.210
 Why?
Phosphates
3
2015
177
0.210
 Why?
South Africa
4
2015
266
0.210
 Why?
Milk, Human
1
2026
174
0.210
 Why?
Lactams, Macrocyclic
2
2026
51
0.210
 Why?
Leucine
2
2026
116
0.200
 Why?
Anemia
2
2016
190
0.200
 Why?
Biomarkers
5
2023
4282
0.200
 Why?
Variola virus
1
2022
3
0.190
 Why?
Smallpox
1
2022
10
0.190
 Why?
Health Personnel
1
2009
749
0.190
 Why?
World Health Organization
1
2022
104
0.180
 Why?
Delivery of Health Care
1
2009
946
0.180
 Why?
Linear Models
2
2014
844
0.170
 Why?
Drug Combinations
4
2026
396
0.170
 Why?
Blood Platelets
1
2025
379
0.170
 Why?
Lopinavir
3
2020
30
0.170
 Why?
Cross-Over Studies
4
2020
608
0.170
 Why?
Dideoxynucleosides
2
2023
24
0.170
 Why?
Point-of-Care Systems
1
2023
188
0.160
 Why?
Phosphorylation
2
2015
1706
0.160
 Why?
Interferons
2
2019
186
0.160
 Why?
Drug Administration Schedule
3
2019
781
0.150
 Why?
Neutrophils
1
2025
1123
0.150
 Why?
Arylamine N-Acetyltransferase
2
2026
8
0.150
 Why?
Nucleic Acids
1
2019
70
0.140
 Why?
Homosexuality, Male
2
2017
231
0.140
 Why?
Quality Control
2
2015
161
0.140
 Why?
Organic Anion Transport Protein 1
2
2008
6
0.130
 Why?
Oxazines
1
2018
37
0.130
 Why?
Directly Observed Therapy
1
2017
15
0.130
 Why?
Bronchoalveolar Lavage Fluid
1
2020
638
0.130
 Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
2017
19
0.130
 Why?
Liver Cirrhosis
1
2019
287
0.130
 Why?
Pharmacogenetics
2
2016
174
0.130
 Why?
Inosine Triphosphate
1
2016
2
0.130
 Why?
Nitriles
2
2021
207
0.120
 Why?
Darunavir
2
2014
20
0.120
 Why?
Anemia, Hemolytic
1
2016
21
0.120
 Why?
Deoxyadenine Nucleotides
1
2016
15
0.120
 Why?
Deoxycytosine Nucleotides
1
2016
13
0.120
 Why?
Guanosine Triphosphate
1
2016
89
0.120
 Why?
Glass
1
2016
46
0.120
 Why?
Pharmacy
1
2017
32
0.120
 Why?
Molecular Targeted Therapy
1
2019
438
0.120
 Why?
Genitalia
1
2016
33
0.120
 Why?
Drug Packaging
1
2016
41
0.120
 Why?
Pregnancy Outcome
1
2020
500
0.120
 Why?
Disease Transmission, Infectious
1
2017
69
0.120
 Why?
Syringes
1
2016
49
0.120
 Why?
Drug and Narcotic Control
1
2016
24
0.120
 Why?
Furans
2
2026
26
0.120
 Why?
Infant
6
2026
10060
0.120
 Why?
Zika Virus
1
2017
136
0.120
 Why?
Viremia
3
2022
160
0.120
 Why?
Pyridones
1
2018
209
0.120
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2011
442
0.120
 Why?
Benzopyrans
2
2026
30
0.120
 Why?
Fibroblast Growth Factors
2
2014
188
0.110
 Why?
Polymers
1
2019
484
0.110
 Why?
Polymorphism, Single Nucleotide
2
2016
2136
0.110
 Why?
Biological Assay
1
2016
129
0.110
 Why?
Cytosol
1
2016
212
0.110
 Why?
Practice Guidelines as Topic
2
2016
1579
0.110
 Why?
Creatinine
2
2018
513
0.110
 Why?
Piperazines
1
2018
375
0.110
 Why?
Rectum
1
2016
182
0.110
 Why?
Population
1
2015
30
0.110
 Why?
Brain Diseases
1
2016
154
0.110
 Why?
Nonlinear Dynamics
1
2015
92
0.110
 Why?
Analgesics
1
2017
230
0.110
 Why?
Chemical and Drug Induced Liver Injury
1
2016
138
0.110
 Why?
Liver Function Tests
1
2015
105
0.110
 Why?
Retrospective Studies
4
2020
17247
0.110
 Why?
Virus Replication
1
2017
519
0.110
 Why?
Pharmaceutical Preparations
1
2016
170
0.110
 Why?
CD4 Lymphocyte Count
2
2015
280
0.110
 Why?
Mental Health Services
1
2019
469
0.100
 Why?
Least-Squares Analysis
1
2014
73
0.100
 Why?
Child, Preschool
5
2026
11835
0.100
 Why?
Adenosine Triphosphate
1
2016
499
0.100
 Why?
Infectious Disease Transmission, Vertical
3
2025
194
0.100
 Why?
Pharmacists
1
2017
258
0.100
 Why?
Administration, Oral
3
2019
862
0.100
 Why?
Metabolic Clearance Rate
2
2018
115
0.100
 Why?
Hypophosphatemia
1
2013
17
0.100
 Why?
Cholecalciferol
1
2014
61
0.100
 Why?
Diphosphates
3
2021
20
0.100
 Why?
Calcitriol
1
2013
57
0.100
 Why?
Double-Blind Method
3
2013
2057
0.100
 Why?
Liver Diseases
1
2016
304
0.100
 Why?
Tablets
2
2023
41
0.100
 Why?
Cytochrome P-450 CYP3A
1
2013
93
0.090
 Why?
Leukocytes
1
2014
296
0.090
 Why?
Desiccation
1
2012
26
0.090
 Why?
Monocytes
1
2015
537
0.090
 Why?
Case-Control Studies
3
2024
3616
0.090
 Why?
Kidney Diseases
1
2016
424
0.090
 Why?
Benzoxazines
1
2012
31
0.090
 Why?
Organic Anion Transporters
1
2011
13
0.090
 Why?
Diabetes Mellitus
1
2020
1092
0.090
 Why?
Levonorgestrel
1
2012
34
0.090
 Why?
Pravastatin
1
2011
45
0.090
 Why?
Interferon-alpha
1
2012
193
0.090
 Why?
Benchmarking
2
2024
188
0.090
 Why?
Nucleosides
1
2011
25
0.090
 Why?
Vitamin D Deficiency
1
2013
190
0.080
 Why?
Contraceptive Agents, Female
1
2012
80
0.080
 Why?
Specimen Handling
1
2012
182
0.080
 Why?
Raltegravir Potassium
1
2010
18
0.080
 Why?
Body Weight
1
2015
969
0.080
 Why?
Models, Statistical
1
2015
671
0.080
 Why?
Hospitals, University
1
2011
176
0.080
 Why?
Mental Disorders
1
2019
1154
0.080
 Why?
Sex Distribution
1
2011
386
0.080
 Why?
Patient Acceptance of Health Care
1
2017
881
0.080
 Why?
Dietary Supplements
1
2014
582
0.080
 Why?
Cohort Studies
2
2019
5988
0.070
 Why?
Sex Characteristics
1
2015
775
0.070
 Why?
Mycobacterium tuberculosis
1
2012
318
0.070
 Why?
Aged
5
2018
26096
0.070
 Why?
Lamivudine
2
2023
65
0.070
 Why?
Time Factors
4
2016
7107
0.070
 Why?
Rosuvastatin Calcium
1
2008
21
0.070
 Why?
Logistic Models
2
2026
2133
0.070
 Why?
Child
5
2026
22670
0.070
 Why?
Immunosuppressive Agents
1
2012
837
0.060
 Why?
Pregnancy
4
2025
7182
0.060
 Why?
Kidney Calculi
1
2007
44
0.060
 Why?
Portugal
1
2006
10
0.060
 Why?
Gene Frequency
1
2008
484
0.060
 Why?
Quebec
1
2006
10
0.060
 Why?
Education, Medical
1
2009
274
0.060
 Why?
Self Report
2
2021
867
0.060
 Why?
Observational Studies as Topic
1
2026
133
0.060
 Why?
Internationality
1
2006
156
0.060
 Why?
Hematocrit
2
2016
108
0.050
 Why?
Dementia
1
2009
325
0.050
 Why?
Referral and Consultation
1
2011
862
0.050
 Why?
Sexual and Gender Minorities
2
2019
259
0.050
 Why?
United States
4
2017
16065
0.050
 Why?
Predictive Value of Tests
2
2019
2115
0.050
 Why?
Postpartum Period
1
2026
372
0.050
 Why?
Isoindoles
1
2022
5
0.050
 Why?
Lipids
1
2008
706
0.050
 Why?
Monkeypox virus
1
2022
23
0.050
 Why?
Risk Assessment
1
2012
3740
0.050
 Why?
Calibration
2
2013
151
0.040
 Why?
Demography
1
2022
282
0.040
 Why?
RNA, Viral
1
2026
690
0.040
 Why?
Treatment Failure
1
2023
360
0.040
 Why?
Computer Simulation
2
2016
1002
0.040
 Why?
Temperature
2
2016
632
0.040
 Why?
Benzamides
1
2022
224
0.040
 Why?
Infant, Newborn
2
2026
6435
0.040
 Why?
Animals
4
2022
37952
0.040
 Why?
Drug Approval
1
2020
93
0.040
 Why?
Tissue Donors
1
2023
419
0.040
 Why?
Dose-Response Relationship, Drug
2
2016
2026
0.040
 Why?
Lactation
1
2020
193
0.040
 Why?
Models, Biological
2
2016
1763
0.040
 Why?
Developing Countries
1
2020
316
0.030
 Why?
Chemistry Techniques, Analytical
1
2018
20
0.030
 Why?
Hair
1
2018
84
0.030
 Why?
Vero Cells
1
2017
83
0.030
 Why?
Flaviviridae
1
2017
10
0.030
 Why?
Inhibitory Concentration 50
1
2017
90
0.030
 Why?
A549 Cells
1
2017
74
0.030
 Why?
Drug Repositioning
1
2017
39
0.030
 Why?
Body Mass Index
1
2026
2437
0.030
 Why?
Pharmaceutical Solutions
1
2016
14
0.030
 Why?
Chromatography, Reverse-Phase
1
2016
27
0.030
 Why?
Breast Feeding
1
2020
446
0.030
 Why?
Drug Storage
1
2016
53
0.030
 Why?
Defective Viruses
1
2016
5
0.030
 Why?
Cities
1
2017
138
0.030
 Why?
Patient Selection
1
2020
733
0.030
 Why?
Acute Disease
1
2019
1035
0.030
 Why?
Solubility
1
2016
240
0.030
 Why?
Drug Compounding
1
2016
107
0.030
 Why?
Methanol
1
2016
44
0.030
 Why?
Alcohol Drinking
1
2023
836
0.030
 Why?
Spermatozoa
1
2016
106
0.030
 Why?
Solutions
1
2016
159
0.030
 Why?
Clinical Trials as Topic
1
2020
1058
0.030
 Why?
Hydrogen-Ion Concentration
1
2016
531
0.030
 Why?
Administration, Inhalation
1
2016
571
0.030
 Why?
Cold Temperature
1
2016
206
0.030
 Why?
Blood-Brain Barrier
1
2016
156
0.030
 Why?
Risk-Taking
1
2017
323
0.030
 Why?
Comorbidity
1
2019
1657
0.030
 Why?
Interleukins
1
2016
248
0.030
 Why?
Pregnancy Complications
1
2020
600
0.030
 Why?
DNA, Viral
1
2016
355
0.030
 Why?
Vitamin D-Binding Protein
1
2013
16
0.030
 Why?
Recurrence
1
2017
1134
0.020
 Why?
Feasibility Studies
1
2017
1109
0.020
 Why?
Parathyroid Hormone
1
2013
114
0.020
 Why?
Mental Health
1
2019
791
0.020
 Why?
Water
1
2016
445
0.020
 Why?
Algorithms
1
2020
1845
0.020
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
261
0.020
 Why?
Therapeutic Equivalency
1
2012
31
0.020
 Why?
Cell Line
1
2017
2821
0.020
 Why?
Alkynes
1
2012
67
0.020
 Why?
Anion Exchange Resins
1
2011
8
0.020
 Why?
Zidovudine
1
2011
77
0.020
 Why?
Food-Drug Interactions
1
2010
11
0.020
 Why?
Reference Standards
1
2011
177
0.020
 Why?
Chemoprevention
1
2010
92
0.020
 Why?
Latent Tuberculosis
1
2011
70
0.020
 Why?
Longitudinal Studies
1
2018
2949
0.020
 Why?
Epithelial Cells
1
2016
1127
0.020
 Why?
Haplotypes
1
2011
498
0.020
 Why?
Cholesterol
1
2011
406
0.020
 Why?
Glomerular Filtration Rate
1
2013
765
0.020
 Why?
Triglycerides
1
2011
520
0.020
 Why?
AIDS Dementia Complex
1
2009
52
0.020
 Why?
Polymorphism, Genetic
1
2011
614
0.020
 Why?
Follow-Up Studies
1
2017
5411
0.020
 Why?
Acquired Immunodeficiency Syndrome
1
2009
237
0.020
 Why?
Cross-Sectional Studies
1
2019
5886
0.020
 Why?
Antiemetics
1
1987
50
0.020
 Why?
Positron-Emission Tomography
1
2009
343
0.020
 Why?
Calcium
1
2013
1189
0.020
 Why?
Vomiting
1
1987
131
0.020
 Why?
Gene Expression Regulation
1
2016
2588
0.020
 Why?
Aged, 80 and over
1
2018
8318
0.010
 Why?
Neuropsychological Tests
1
2009
1134
0.010
 Why?
Brain
1
2016
2934
0.010
 Why?
Age Factors
1
2011
3338
0.010
 Why?
Alzheimer Disease
1
2009
629
0.010
 Why?
Magnetic Resonance Imaging
1
2009
3892
0.010
 Why?
Antineoplastic Agents
1
1987
2207
0.010
 Why?
Flunitrazepam
1
1987
3
0.000
 Why?
Metoclopramide
1
1987
19
0.000
 Why?
Methylprednisolone
1
1987
59
0.000
 Why?
Kiser's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (362) concept(s)
_
Co-Authors Expand Description
See all (31) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)